Data as-of 2026-08-07 close — every name in this cut carries a fresh bar this scan.

PFE and VEEV both spiked into overbought while CVS and ZTS both broke the other way: PFE's RSI jumped from 57.2 to 74.7 (+17.5 points, now overbought) and VEEV's from 62.1 to 75.6, now the cut's highest print in a "parabolic" regime. CVS moved the opposite direction — RSI 50.5 → 32.1, now the cut's only oversold name — and ZTS dropped from 51.1 to 39.6 on a -5.97% single day, its regime downgraded to "collapse." Elsewhere the large-cap complex extended: AMGN (64.9 → 72.3) and TMO (68.8 → 71.6) both crossed above RSI 70, and ISRG relapsed back to 51.3 after climbing out of the same oversold band it sat in two scans ago.

Source: healthcare.json (the broader universe, not the narrower healthcare-scan.json cut — consistent with the prior scan). Latest bar 2026-08-07 for every name in this cut, including new entrant XLV. Prior scan: 2026-07-31-healthcare-scan.

PFE and VEEV both posted the session's sharpest gains. PFE's RSI climbed from 57.2 to 74.7 (+13.2% over 30 days, change30d per healthcare.json), crossing into overbought territory even as its regime classifier still reads "basing." VEEV moved from 62.1 to 75.6, +22.48% over 30 days and +38.55% over three months (change3m) — the cut's new highest RSI print, now in a "parabolic" regime.

CVS and ZTS moved the other direction, and both broke through structural lines. CVS's RSI fell from 50.5 to 32.1 on -8.36% over the week — the cut's only sub-40 print and its only name inside the oversold band. ZTS dropped from 51.1 to 39.6 on a -5.97% single-day move (change1d), with the regime classifier downgraded to "collapse" — the sharpest single-day break in the cut.

The large-cap complex kept extending. AMGN's RSI crossed above 70 (64.9 → 72.3, +11.67% over 30 days) and TMO's did the same (68.8 → 71.6, +16.44% over 30 days) — both names now sit in the overbought band alongside PFE and VEEV, four names above RSI 70 versus none two scans ago.

ISRG relapsed for the second time. RSI moved from 39.9 to 51.3, clearing the oversold band it had dropped back into last scan — the identical ticker showing the identical bounce visible in this session's biotech cut — but the regime classifier still reads "collapse," and the trend remains strong-down DC. XLV, the sector ETF, enters this cut's universe for the first time this scan, reading RSI 61.8 in an "uptrend" regime.

• PFE spiked into overbought. RSI 57.2 → 74.7 (+17.5 points), +13.2% over 30 days.
• VEEV posted the cut's new high print. RSI 62.1 → 75.6, regime now "parabolic," +22.5% over 30 days.
• CVS broke into oversold. RSI 50.5 → 32.1, -8.36% over the week — the cut's only sub-40 name.
• ZTS dropped into "collapse." RSI 51.1 → 39.6 on a -5.97% single-day move.
• AMGN and TMO both crossed above RSI 70. AMGN: 64.9 → 72.3. TMO: 68.8 → 71.6. Four names now sit above 70, versus none last scan.
• ISRG relapsed out of the oversold band it sat in last scan. RSI 39.9 → 51.3, but regime still reads "collapse" — the same ticker, same relapse pattern visible in this session's biotech cut.
• XLV enters the universe this scan — RSI 61.8, "uptrend" regime, no prior-scan comparison available.
• No stale bars this scan — SYK, last scan's one-session-stale name, carries a fresh 2026-08-07 close.

RSI measures how stretched a stock is over the past 14 sessions — under 30 is oversold, over 70 is overbought/extended. vs SMA20 is the price gap to the 20-day average. vs VWAP is the premium over the average price paid by current holders — a useful gut check on how much of a move is unrealized gain that could get sold into weakness. Trend combines direction/strength with a cross signal: GC (golden cross) is structurally healthier than DC (death cross). A stock whose RSI clears an oversold band while its regime classifier still reads "collapse" — like ISRG here — means the bounce hasn't been confirmed by the underlying structure; treat it as "watch," not "buy."

None.

CVS (32.1) and ZTS (39.6) — the cut's two damaged names this scan, both moving DOWN into the band rather than out of it.

• Collapse-regime tier: ISRG, ZTS — despite RSI recoveries or drops on the surface, both remain structurally flagged.
• Downtrend-regime tier: SYK, MDT — cooled or steady, no regime upgrade.
• Pullback-regime tier: ABT, CVS, MRNA, HROW — mixed reads, none confirmed either way.
• Basing-regime tier: PFE, GILD — PFE now overbought within a "basing" tag, worth confirming next scan.
• Uptrend-regime tier: MRK, LLY, BIIB, JNJ, UNH, VRTX, GH, XLV — the cleanest zone in the cut, 8 names.
• Breakout-regime tier: DXCM, AMGN, TMO — three of the four overbought names.
• Parabolic-regime tier: VEEV — the cut's single most extended name.

• PFE and VEEV both spiked into overbought this scan — do those moves hold, or do they give back the way the large-cap complex did two scans ago?
• CVS broke into oversold and ZTS dropped into "collapse" on a sharp single day — does either find a floor, or does the damage compound?
• ISRG relapsed back above RSI 40 for the second scan running (also visible in the biotech cut) while its regime still reads "collapse" — does that gap finally close, or does it bounce again without confirmation?
• XLV enters the universe this scan with no prior-scan baseline — does next scan show it tracking the sector's large-cap complex or diverging?

• Tape data (price/RSI/SMA/returns): full-scan pre-computed summaries as of the 2026-08-07 close — healthcare.